We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current NPTH market cap is 11M. The company's latest EPS is CAD -0.0129 and P/E is -14.73.
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 47.64M | 60.86M | 62.65M | 66.1M | 72.81M |
| Operating Income | -820k | -1.84M | -3.71M | 442k | 1.26M |
| Net Income | -5.06M | -3.23M | -4.14M | -107k | -728k |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 46.12M | 51.34M | 45.09M | 41.78M | 41.3M |
| Total Liabilities | 18.5M | 25.51M | 23.43M | 19.94M | 19.87M |
| Total Equity | 27.62M | 25.83M | 21.65M | 21.84M | 21.43M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -646k | 1.92M | 738k | 3.03M | 2.61M |
| Investing | 2.68M | -3.5M | -1.67M | 1.59M | -1.11M |
| Financing | 7.93M | -3.37M | -3.45M | -2.96M | -1.75M |
| Market Cap | 11M |
| Price to Earnings Ratio | -14.73 |
| Price to Sales Ratio | 0.15 |
| Price to Cash Ratio | 3.67 |
| Price to Book Ratio | 0.5 |
| Dividend Yield | - |
| Shares Outstanding | 56.39M |
| Average Volume (1 week) | 85.4k |
| Average Volume (1 Month) | 104.08k |
| 52 Week Change | 14.71% |
| 52 Week High | 0.245 |
| 52 Week Low | 0.155 |
| Spread (Intraday) | 0.01 (2.56%) |
| Company Name | Neupath Health Inc |
| Address |
181 bay street, suite 2100 toronto, ontario M5J 2T3 |
| Website | https://www.neupath.com |
| Industry | unit inv tr, closed-end mgmt (6726) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
